Escoba, C.A.; Duarte, K.S.L.; Desabille, K.E.L.; Estella, K.D
ABSTRACT
The study was conducted to determine the effectivity of Pleurotus ostreatus (oyster mushroom)
ethanolic extract on the hematopoietic activity among Oryctolagus cuniculus. Pleurotus
ostreatus (oyster mushroom) has been found to contain vitamins B1
(thiamin), B2 (riboflavin), B5 (niacin), B6 (pyridoxine) and B7 (biotin). The
phytochemical screening of the mushroom extract revealed the presence of
tannins, terpenoids, and glycosides.
A total of 20 Oryctolagus cuniculus (rabbits) were randomly
assigned and employed into four groups. All showed a normal hematopoietic
activity prior to testing. There is statistical significance between
treatments and time, and interaction of treatments and time; RBC
(treatment=.034, time=.021, .interaction=.003); hematocrit = (treatment=.032,
time=.024, interaction=004); hemoglobin (treatment=.034, time=.021,
.interaction=.003).
Based on the gathered data and results, the researchers
concluded that Pleurotus ostreatus (oyster mushroom) ethanolic
extract has a potential hematopoietic effect among Oryctolagus cuniculus (rabbits).
RECOMMENDATIONS
The researchers of this study yearn to improve the
following:
1. That the future researchers might improve the methodology
used by the proponents in this experimentation.
2. That there will be additional parameters to be studied
upon aside from the red blood cell count, hematocrit and hemoglobin.
3. That there will be induction of any hematological
abnormalities that could prove the effectiveness of Pleurotus ostreatus (oyster
mushroom) and show that there is possibility that it could be used as an
alternative treatment.
No comments:
Post a Comment